This is a Validated Antibody Database (VAD) review about human prostate specific antigen, based on 30 published articles (read how Labome selects the articles), using prostate specific antigen antibody in all methods. It is aimed to help Labome visitors find the most suited prostate specific antigen antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
prostate specific antigen synonym: APS; KLK2A1; PSA; hK3

Santa Cruz Biotechnology
mouse monoclonal (A67-B/E3)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 1e
Santa Cruz Biotechnology prostate specific antigen antibody (Santa Cruz, sc-7316) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 1e). Biomedicines (2021) ncbi
mouse monoclonal (A67-B/E3)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology prostate specific antigen antibody (SantaCruz, sc-7316) was used in western blot on human samples (fig 3b). Eur J Pharmacol (2017) ncbi
mouse monoclonal (A67-B/E3)
  • immunohistochemistry; human; 1:500; fig 2
Santa Cruz Biotechnology prostate specific antigen antibody (santa Cruz, sc-7316) was used in immunohistochemistry on human samples at 1:500 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (A67-B/E3)
  • western blot; human; 1:400; fig 1
Santa Cruz Biotechnology prostate specific antigen antibody (Santa Cruz, sc-7316) was used in western blot on human samples at 1:400 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (A67-B/E3)
  • western blot; human; 1:1000; fig 1
In order to research induction of epithelial-to-mesenchymal transition by Polo-like kinase 1 and promotion of epithelial cell motility by activating CRAF/ERK signaling, Santa Cruz Biotechnology prostate specific antigen antibody (Santa Cruz, sc-7316) was used in western blot on human samples at 1:1000 (fig 1). elife (2016) ncbi
mouse monoclonal (A67-B/E3)
  • western blot; human; fig 2
Santa Cruz Biotechnology prostate specific antigen antibody (Santa Cruz, sc-7316) was used in western blot on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (A67-B/E3)
  • western blot; human; fig 2
Santa Cruz Biotechnology prostate specific antigen antibody (Santa Cruz, SC-7316) was used in western blot on human samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (A67-B/E3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1
Santa Cruz Biotechnology prostate specific antigen antibody (SantaCruz, A67-B/E3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1). Clin Cancer Res (2016) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1
Santa Cruz Biotechnology prostate specific antigen antibody (SantaCruz, A67-B/E3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1). Clin Cancer Res (2016) ncbi
mouse monoclonal (A67-B/E3)
  • western blot; human; fig 2f
Santa Cruz Biotechnology prostate specific antigen antibody (Santa Cruz, A67-B/E13) was used in western blot on human samples (fig 2f). Oncotarget (2015) ncbi
mouse monoclonal (A67-B/E3)
  • western blot; human
Santa Cruz Biotechnology prostate specific antigen antibody (Santa Cruz Biotechnology, sc-7316) was used in western blot on human samples . Am J Physiol Endocrinol Metab (2011) ncbi
Abcam
domestic rabbit monoclonal (EP1588Y)
  • western blot; human; 1:1000; loading ...; fig 2a
Abcam prostate specific antigen antibody (Abcam, 76113) was used in western blot on human samples at 1:1000 (fig 2a). Mol Ther Nucleic Acids (2021) ncbi
domestic rabbit monoclonal (EP1588Y)
  • ELISA; human
Abcam prostate specific antigen antibody (Abcam, Ab76113) was used in ELISA on human samples . Analyst (2015) ncbi
Invitrogen
domestic rabbit polyclonal
In order to examine the sera of patients with prostate abnormalities for the presence of anti-prostate-specific antigen antibodies, Invitrogen prostate specific antigen antibody (Pierce, PA1-38514) was used . Andrologia (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2A8)
  • western blot; human; 1:2000; loading ...; fig 5f
Cell Signaling Technology prostate specific antigen antibody (CST, 5877) was used in western blot on human samples at 1:2000 (fig 5f). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D11E1)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology prostate specific antigen antibody (Cell Signaling, 2475S) was used in western blot on human samples (fig 5b). Cancer Sci (2020) ncbi
domestic rabbit monoclonal (D6B1)
  • western blot; human; 1:1000; loading ...; fig 5b
Cell Signaling Technology prostate specific antigen antibody (Cell Signaling, 5365S) was used in western blot on human samples at 1:1000 (fig 5b). Mol Cancer Ther (2019) ncbi
domestic rabbit monoclonal (D6B1)
  • western blot; human; 1:500; loading ...; fig 1e
Cell Signaling Technology prostate specific antigen antibody (Cell Signaling, 5365) was used in western blot on human samples at 1:500 (fig 1e). elife (2019) ncbi
domestic rabbit monoclonal (D2A8)
  • immunoprecipitation; human; loading ...; fig 1f
Cell Signaling Technology prostate specific antigen antibody (Cell Signaling, (5877) was used in immunoprecipitation on human samples (fig 1f). Oncogene (2018) ncbi
domestic rabbit monoclonal (D6B1)
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology prostate specific antigen antibody (Cell Signaling, 5365) was used in western blot on human samples at 1:1000 (fig 4). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (D6B1)
  • western blot; human; fig 4b
Cell Signaling Technology prostate specific antigen antibody (Cell Signaling Technology, 5365) was used in western blot on human samples (fig 4b). Cell Cycle (2015) ncbi
domestic rabbit monoclonal (D6B1)
  • western blot; human; 1:1000
Cell Signaling Technology prostate specific antigen antibody (Cell Signaling, 5365) was used in western blot on human samples at 1:1000. Cell (2014) ncbi
Dako
domestic rabbit polyclonal
  • immunohistochemistry; human; 1 ug/ml; fig s5d
Dako prostate specific antigen antibody (DAKO, A0562) was used in immunohistochemistry on human samples at 1 ug/ml (fig s5d). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3h
Dako prostate specific antigen antibody (Dako, A0562) was used in western blot on human samples at 1:1000 (fig 3h). Nat Commun (2020) ncbi
mouse monoclonal (ER-PR8)
  • western blot; human; 1:500; loading ...; fig 2b
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, Dako prostate specific antigen antibody (Dako, M0750) was used in western blot on human samples at 1:500 (fig 2b). Science (2016) ncbi
mouse monoclonal (ER-PR8)
  • immunohistochemistry; human; 1:50; fig 2
In order to study low grade urothelial carcinoma mimicking transitional metaplasia and basal cell hyperplasia in needle prostate biopsy, Dako prostate specific antigen antibody (Dako, ER-PR8) was used in immunohistochemistry on human samples at 1:50 (fig 2). Int Braz J Urol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; fig 5d
  • western blot; human; 1:20,000; loading ...; fig 3a
Dako prostate specific antigen antibody (Dako, A0562) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 5d) and in western blot on human samples at 1:20,000 (fig 3a). Oncotarget (2016) ncbi
mouse monoclonal (ER-PR8)
  • immunohistochemistry - paraffin section; human; 1:4000; fig st2
Dako prostate specific antigen antibody (Dako, ER-PR8) was used in immunohistochemistry - paraffin section on human samples at 1:4000 (fig st2). Oncotarget (2016) ncbi
Meridian Life Science
mouse monoclonal (8A6)
  • ELISA; human
In order to optimize a method to distinguish benign prostatic hypertrophy from prostate cancer, Meridian Life Science prostate specific antigen antibody (Meridian, M86806M) was used in ELISA on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (B727M)
  • ELISA; human
In order to optimize a method to distinguish benign prostatic hypertrophy from prostate cancer, Meridian Life Science prostate specific antigen antibody (Meridian, M66276M) was used in ELISA on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (B728M)
  • ELISA; human
In order to optimize a method to distinguish benign prostatic hypertrophy from prostate cancer, Meridian Life Science prostate specific antigen antibody (Meridian, M66280M) was used in ELISA on human samples . PLoS ONE (2015) ncbi
Leica Biosystems
mouse monoclonal (35H9)
  • immunohistochemistry - paraffin section; human; fig 1g
Leica Biosystems prostate specific antigen antibody (Leica, 35H9) was used in immunohistochemistry - paraffin section on human samples (fig 1g). Diagn Cytopathol (2017) ncbi
mouse monoclonal (35H9)
  • immunohistochemistry - paraffin section; human; 1:100
Leica Biosystems prostate specific antigen antibody (Novocastra, NCL-PSA-431) was used in immunohistochemistry - paraffin section on human samples at 1:100. Virchows Arch (2014) ncbi
Articles Reviewed
  1. Bamodu O, Wang Y, Yeh C, Ho C, Chiang Y, Kao W, et al. Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer. Biomedicines. 2021;9: pubmed publisher
  2. Goel S, Bhatia V, Kundu S, Biswas T, Carskadon S, Gupta N, et al. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. Nat Commun. 2021;12:5325 pubmed publisher
  3. Risbridger G, Clark A, Porter L, Toivanen R, Bakshi A, Lister N, et al. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. Nat Commun. 2021;12:5049 pubmed publisher
  4. Corbin J, Georgescu C, Wren J, Xu C, Asch A, Ruiz Echevarría M. Seed-mediated RNA interference of androgen signaling and survival networks induces cell death in prostate cancer cells. Mol Ther Nucleic Acids. 2021;24:337-351 pubmed publisher
  5. Vatapalli R, Sagar V, Rodriguez Y, Zhao J, Unno K, Pamarthy S, et al. Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Nat Commun. 2020;11:4153 pubmed publisher
  6. Zhao J, Zhang Y, Liu X, Zhu F, Xie F, Jiang C, et al. RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression. Cancer Sci. 2020;111:369-382 pubmed publisher
  7. Mao N, Gao D, Hu W, Hieronymus H, Wang S, Lee Y, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18:1577-1586 pubmed publisher
  8. Lee E, Wongvipat J, Choi D, Wang P, Lee Y, Zheng D, et al. GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance. elife. 2019;8: pubmed publisher
  9. Li N, Truong S, Nouri M, Moore J, Al Nakouzi N, Lubik A, et al. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3. Oncogene. 2018;37:2313-2325 pubmed publisher
  10. Jia L, Jiang Y, Michael C. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma. Diagn Cytopathol. 2017;45:998-1004 pubmed publisher
  11. Hennenberg M, Tamalunas A, Wang Y, Keller P, Schott M, Strittmatter F, et al. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region. Eur J Pharmacol. 2017;803:39-47 pubmed publisher
  12. Fang F, Qin Y, Hao F, Li Q, Zhang W, Zhao C, et al. CD147 modulates androgen receptor activity through the Akt/Gsk-3?/?-catenin/AR pathway in prostate cancer cells. Oncol Lett. 2016;12:1124-1128 pubmed
  13. Sui X, Hu Y, Zhang C, Pan H, Li D. Prostate cancer metastasis to the distal phalanx of the left hallux: The first confirmed case and literature review. Oncol Lett. 2016;12:1074-1078 pubmed
  14. Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80 pubmed publisher
  15. Arista Nasr J, Martinez Benitez B, Bornstein Quevedo L, Aguilar Ayala E, Aleman Sanchez C, Ortiz Bautista R. Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy. Int Braz J Urol. 2016;42:247-52 pubmed publisher
  16. Wang Y, Gratzke C, Tamalunas A, Wiemer N, Ciotkowska A, Rutz B, et al. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate. PLoS ONE. 2016;11:e0153312 pubmed publisher
  17. Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  18. Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, et al. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget. 2016;7:69397-69411 pubmed publisher
  19. Meller S, Meyer H, Bethan B, Dietrich D, Maldonado S, Lein M, et al. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer. Oncotarget. 2016;7:1421-38 pubmed publisher
  20. Guo J, Huang X, Wang H, Yang H. Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells. PLoS ONE. 2015;10:e0140745 pubmed publisher
  21. Jokerst J, Chen Z, Xu L, Nolley R, Chang E, Mitchell B, et al. A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers. PLoS ONE. 2015;10:e0139484 pubmed publisher
  22. Xu S, Wang T, Song W, Jiang T, Zhang F, Yin Y, et al. The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism. Sci Rep. 2015;5:13528 pubmed publisher
  23. Leclerc B, Charlebois R, Chouinard G, Allard B, Pommey S, Saad F, et al. CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer. Clin Cancer Res. 2016;22:158-66 pubmed publisher
  24. Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959-86 pubmed
  25. Madaboosi N, Soares R, Chu V, Conde J. A microfluidic immunoassay platform for the detection of free prostate specific antigen: a systematic and quantitative approach. Analyst. 2015;140:4423-33 pubmed publisher
  26. Zhang Z, Chen L, Wang H, Ahmad N, Liu X. Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer. Cell Cycle. 2015;14:2142-8 pubmed publisher
  27. Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176-187 pubmed publisher
  28. Seipel A, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J, et al. Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch. 2014;465:559-65 pubmed publisher
  29. Lokant M, Naz R. Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis). Andrologia. 2015;47:328-32 pubmed publisher
  30. Hsu F, Yang M, Lin E, Tseng C, Lin H. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Am J Physiol Endocrinol Metab. 2011;300:E902-8 pubmed publisher